NF-Y-dependent cyclin B2 expression in colorectal adenocarcinoma

Clinical Cancer Research

Volumn 13, Issue 3, 2007, Pages 858-867

  Park, Seon Hwa ^a   Yu, Gyung Ran ^a   Kim, Woo Ho ^b   Moon, Woo Sung ^a   Kim, Jong Hun ^a   Kim, Dae Ghon ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CYCLIN B2; CYCLIN B2 ANTIBODY; CYCLINE; NUCLEAR FACTOR Y; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; COLON ADENOCARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; CCAAT-BINDING FACTOR; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYCLIN B; CYTOPLASM; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC;

EID: 33847377524     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-1461     Document Type: Article

References (48)

1. Evans T, Rosenthal E, Youngblom J, Distel D, Hunt T. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 1983;33:389-96.
2. Epstein CB, Cross FR. CLB5: a novel B cyclin from budding yeast with a role in S phase. Genes 1992;6:1695-706.
3. Fitch I, Dahmann C, Surana U, et al. Characterization of four B-type cyclin genes of the budding yeast Saccharomyces cerevisiae. Mol Biol Cell 1992;3:805-18.
4. Chapman DL, Wolgemuth DJ. Isolation of the murine cyclin B2 cDNA and characterization of the lineage and temporal specificity of expression of the B1 and B2 cyclins during oogenesis, spermatogenesis, and early embryogenesis. Development 1993;118:229-40.
5. Jackman M, Firth M, Pines J. Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus. EMBO J 1995;14:1646-54.
6. Brandeis M, Hunt T. The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase. EMBO J 1996;15:5280-9.
7. Liu JH, Wei S, Burnette PK, Gamero AM, Hutton M, Djeu JY. Functional association of TGF-β receptor II with cyclin B. Oncogene 1999;18:269-75.
8. Furuno N, den Elzen N, Pines J. Human cyclin A is required for mitosis until mid prophase. J Cell Biol 1999;147:295-306.
9. Hagting A, Jackman M, Simpson K, Pines J. Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal. Curr Biol 1999;9:680-9.
10. Hagting A, Karlsson C, Clute P, Jackman M, Pines J. MPF localization is controlled by nuclear export. EMBO J 1998;17:4127-38.
11. Clute P, Pines J. Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol 1999;1:82-7.
12. Brandeis M, Rosewell I, Carrington M, et al. Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. Proc Natl Acad Sci U S A 1998;95:4344-9.
13. Krause K, Wasner M, Reinhard W, et al. The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res 2000;28:4410-8.
14. Zwicker J, Muller R. Cell-cycle regulation of gene expression by transcriptional repression. Trends Genet 1997;13:3-6.
15. Zwicker J, Lucibello FC, Wolfraim LA, et al. Cell cycle regulation of the cyclin A, cdc25C, and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J 1995;14:4514-22.
16. Katula KS, Wright KL, Paul H, et al. Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements. Cell Growth Differ 1997;8:811-20.
17. Farina A, Manni I, Fontemaggi G, et al. Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex. Oncogene 1999;18:2818-27.
18. Bolognese F, Wasner M, Dohna CL, et al. The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated. Oncogene 1999;18:1845-53.
19. Mantovani R. A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res 1998;26:1135-43.
20. Kim JH, You KR, Kim IH, Cho BH, Kim CY, Kim DG. Over-expression of the ribosomal protein L36a gene is associated with cellular proliferation in hepatocellular carcinoma. Hepatology 2004;39:129-38.
21. Mantovani R, Li XY, Pessara U, Hooft van Huisjduijnen R, Benoist C, Mathis D. Dominant negative analogs of NF-YA. J Biol Chem 1994;269:20340-6.
22. Lange-zu D, Brandeis M, Berr F, Mossner J, Engeland K. A CDE/CHR tandem element regulates cell cycle-dependent repression of cyclin B2 transcription. FEBS Lett 2000;484:77-81.
23. Wasner M, Haugwitz U, Reinhard W, et al. Three CCAAT-boxes and a single cell cycle genes homology region (CHR) are the major regulating sites for transcription from the human cyclin B2 promoter. Gene 2003;312:225-37.
24. Park JG, Oie HK, Sugarbaker PH, et al. Characteristics of cell lines established from human colorectal carcinoma. Cancer Res 1987;47:6710-8.
25. Sciortino S, Gurtner A, Manni I, et al. The cyclin B1 gene is actively transcribed during mitosis in HeLa cells. EMBO Rep 2001;2:1018-23.
26. Frontini M, Imbriano C, Manni I, Mantovani R. Cell cycle regulation of NF-YC nuclear localization. Cell Cycle 2004;3:217-22.
27. Kelman Z. PCNA: structure, functions, and interactions. Oncogene 1997;14:629-40.
28. Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-94.
29. McKay JA, Douglas JJ, Ross VG, et al. Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J Pathol 2002;196:386-93.
30. Tornaletti S, Pfeifer GP. UV light as a footprinting agent: modulation of UV-induced DNA damage by transcription factors bound at the promoters of three human genes. J Mol Biol 1995;249:714-28.
31. Weng JJ, Yung BY. Nucleophosmin/B23 regulates PCNA promoter through YY1. Biochem Biophys Res Commun 2005;335:826-31.
32. Wang A, Yoshimi N, Ino N, Tanaka T, Mori H. Overexpression of cyclin B1 in human colorectal cancers. J Cancer Res Clin Oncol 1997;123:124-7.
33. Soria JC, Jang SJ, Khuri FR, et al. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 2000;60:4000-4.
34. Sarafan-Vasseur N, Lamy A, Bourguignon J, et al. Overexpression of B-type cyclins alters chromosomal segregation. Oncogene 2002;21:2051-7.
35. Di Agostino S, Strano S, Emiliozzi V, et al. Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation. Cancer Cell 2006;10:191-202.
36. Wasner M, Tschop K, Spiesbach K, et al. Cyclin B1 transcription is enhanced by the p300 coactivator and regulated during the cell cycle by a CHR-dependent repression mechanism. FEBS Lett 2003;536:66-70.
37. Salsi S, Caretti G, Wasner M, et al. Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function. J Biol Chem 2003;278:6642-50.
38. Izumi H, Molander C, Penn LZ, Ishisaki A, Kohno K, Funa K. Mechanism for the transcriptional repression by c-Myc on PDGF β-receptor. J Cell Sci 2001;114:1533-44.
39. van Ginkel PR, Hsiao KM, Schjerven H, Farnham PJ. E2F-mediated growth regulation requires transcription factor cooperation. J Biol Chem 1997;272:18367-74.
40. Alder H, Yoshinouchi M, Prystowsky MB, Appasamy P, Baserga R. A conserved region in intron 1 negatively regulates the expression of the PCNA gene. Nucleic Acids Res 1992;20:1769-75.
41. 1/S transition by peripheral cues. Biochem Pharmacol 2000;60:1179-84.
42. Hu Q, Bhattacharya C, Maity SN. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase IIα. Conventional CBF activation domains are not required. J Biol Chem 2002;277:37191-200.
43. Caretti G, Salsi V, Vecchi C, Imbriano C, Mantovani R. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J Biol Chem 2003;278:435-40.
44. Romier C, Cocchiarella F, Mantovani R, Moras D. The NF-YB/NF-YC structure gives insight into DNA binding and transcription regulation by CCAAT factor NF-Y. J Biol Chem 2003;278:1336-45.
45. Kahle J, Baake M, Doenecke D, Albig W. Subunits of the heterotrimeric transcription factor NF-Y are imported into the nucleus by distinct pathways involving importin β and importin 13. Mol Cell Biol 2005;25:5339-54.
46. Latron F, Jotterand-Bellomo M, Maffei A, et al. Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. Proc Natl Acad Sci U S A 1988;85:2229-33.
47. Currie RA. Biochemical characterization of the NF-Y transcription factor complex during B lymphocyte development. J Biol Chem 1998;273:18220-9.
48. Banerjee SK, Weston AP, Zoubine MN, Campbell DR, Cherian R. Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma: relationship to cell death, proliferation, and transformation. Am J Pathol 2000;156:217-25.